Related Funds
Funds with similar focus
Fund Name | Location |
Clean Pacific Ventures | California, San Francisco, United States |
Dainippon Sumitomo Pharma | Japan, Osaka, Osaka Prefecture |
Diehl Ventures | Bayern, Germany, Nuremberg |
eCatalogs | California, Los Angeles, United States |
Foresight 4 VCT plc | - |
Security Pacific National Bank | California, Los Angeles, United States |
WFD Ventures | New York, New York, United States |
Wolverine Trading | Chicago, Illinois, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AusperBio | $37M | 14 Jul 2024 | Hangzhou, Zhejiang, China | ||
MAXVAX | $46M | 15 Jun 2024 | Shuangliu, Sichuan, China | ||
Curegene | $15M | 31 Jan 2024 | Shanghai, Shanghai, China | ||
Miele Medicine | $15M | 30 Mar 2023 | Suzhou, Jiangsu, China | ||
Zenshine Pharma | 11 Mar 2023 | Nanjing, Jiangsu, China | |||
Zeidman Pharmaceuticals | $15M | 10 Mar 2023 | Pudong, Shandong, China | ||
Aurora Yaocheng | 11 Oct 2022 | Shanghai, China | |||
China Immunotech | 18 Jul 2022 | Changping, Beijing, China | |||
HanBio Therapeutics | $40M | 28 Jan 2022 | Shanghai, Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AusperBio | $37M | 14 Jul 2024 | Hangzhou, Zhejiang, China | ||
MAXVAX | $46M | 15 Jun 2024 | Shuangliu, Sichuan, China | ||
Curegene | $15M | 31 Jan 2024 | Shanghai, Shanghai, China | ||
Miele Medicine | $15M | 30 Mar 2023 | Suzhou, Jiangsu, China | ||
Zenshine Pharma | 11 Mar 2023 | Nanjing, Jiangsu, China | |||
Zeidman Pharmaceuticals | $15M | 10 Mar 2023 | Pudong, Shandong, China | ||
Aurora Yaocheng | 11 Oct 2022 | Shanghai, China | |||
China Immunotech | 18 Jul 2022 | Changping, Beijing, China | |||
HanBio Therapeutics | $40M | 28 Jan 2022 | Shanghai, Shanghai, China |